Femasys Inc. (FEMY)
NASDAQ: FEMY · IEX Real-Time Price · USD
1.270
-0.060 (-4.51%)
At close: Apr 26, 2024, 4:00 PM
1.260
-0.010 (-0.79%)
After-hours: Apr 26, 2024, 7:52 PM EDT
Femasys Market Cap
Femasys has a market cap or net worth of $28.07 million as of April 26, 2024. Its market cap has increased by 175.16% in one year.
Market Cap
28.07M
Enterprise Value
13.05M
1-Year Change
175.16%
Ranking
Category
Stock Price
$1.27
Market Cap Chart
Since the IPO on June 18, 2021, Femasys's market cap has decreased from $152.90M to $28.07M, a decrease of -81.64%. That is a compound annual growth rate of -44.75%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 26, 2024 | 28.10M | -4.42% |
Apr 25, 2024 | 29.40M | - |
Apr 24, 2024 | 29.40M | - |
Apr 23, 2024 | 29.40M | 4.63% |
Apr 22, 2024 | 28.10M | -3.77% |
Apr 19, 2024 | 29.20M | 0.69% |
Apr 18, 2024 | 29.00M | 1.05% |
Apr 17, 2024 | 28.70M | -1.03% |
Apr 16, 2024 | 29.00M | -2.03% |
Apr 15, 2024 | 29.60M | 3.14% |
Apr 12, 2024 | 28.70M | -7.12% |
Apr 11, 2024 | 30.90M | -2.22% |
Apr 10, 2024 | 31.60M | -7.87% |
Apr 9, 2024 | 34.30M | -1.72% |
Apr 8, 2024 | 34.90M | -6.43% |
Apr 5, 2024 | 37.30M | -1.32% |
Apr 4, 2024 | 37.80M | -5.50% |
Apr 3, 2024 | 40.00M | 3.90% |
Apr 2, 2024 | 38.50M | 1.32% |
Apr 1, 2024 | 38.00M | 10.79% |
Mar 28, 2024 | 34.30M | 7.86% |
Mar 27, 2024 | 31.80M | -2.15% |
Mar 26, 2024 | 32.50M | -6.88% |
Mar 25, 2024 | 34.90M | -2.79% |
Mar 22, 2024 | 35.90M | -3.49% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
SeaStar Medical Holding | 31.44M |
ImmunoPrecise Antibodies | 31.42M |
CASI Pharmaceuticals | 30.82M |
MiNK Therapeutics | 30.23M |
Singular Genomics Systems | 29.68M |
Daré Bioscience | 29.09M |
Aprea Therapeutics | 29.05M |
Spruce Biosciences | 28.85M |